| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Stimunity Turn cancer immunotherapies active in most patient Stimunity is a startup company from Institut Curie which develops bio-pharmaceuticals to treat patients that do not respond to immunotherapy in cancer. | 3 | 2 | 0 | 5 |
 | Verne Business Excellence Verne Business Excellence biedt een standaard platform voor automatiseren van verzekeringsprocessen. Agile Software Development, Operational Excellence, Business Excellence, and Automation Type: | 5 | 4 | 0 | 13 |
 | AJA Pharma [Automatic translation follows] Aja Pharmaceutical Industries Company was established as one of the Saudi chemical companies, and it is the company known internationally as a leading Saudi joint stock company since its founding in 1972 AD. Aga Pharma owns a factory that is considered a distinctive technological mark among pharmaceutical factories, with its huge capabilities in accordance with the latest internationally known technologies in the field of the pharmaceutical industry. The factory is located in the industrial city of Hail in the north of the Kingdom of Saudi Arabia, and aspires to provide the highest and latest levels of quality … Type: | 1 | 1 | 0 | 282 |
 | Intarcia Therapeutics, Inc. We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking. We are committed to seeking better outcomes which compels us to ask questions that have not been asked before or remain unresolved. We are driven by a desire to create meaningful impact across business, health and society to ease the burden on people living with chronic diseases. Intarcia is a rapidly emerging biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease. Our cross-disciplinary teams include forward-thinking scientists and entrepreneurs collaborating in a fast-paced environment redefining the future of medicine. Type: | 1 | 1 | 0 | 80 |
 | Greiner Bio-One SAS France [Automatic translation follows] making a difference Greiner Bio-One International GmbH is a global medical technology company with operations in 100 countries. It is part of Greiner AG, based in Kremsmünster, Austria. The pre-analytical division develops innovative solutions and products dedicated to the collection and analysis of biological samples (blood, urine and saliva) for hospitals and medical biology laboratories. Our goal: to make the daily lives of healthcare professionals safer. In France (Greiner Bio-One SAS France), the pre-analytical division is divided into three ranges: - The VACUETTE® range - The PERI-ANALYTIC range - The SERVICES range The BioScience division develops, produces … Type: | 2 | 0 | 0 | 8 |
 | Sofinnova Investments Innovation for Life Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients. We invest in both private and public equity companies. Sofinnova actively partners with entrepreneurs across all stages of company formation, we are long-term investors with extensive scientific expertise, vast industry knowledge, and a track record of helping forge the path from drug development and navigating the regulatory process to company building and IPO or M&A. Founded in 1976, Sofinnova has a long legacy of building what we believe are great companies in both the U.S. and … Type: | 6 | 0 | 0 | 50 |
 | Université Sorbonne Paris Cité [Automatic translation follows] Sorbonne Paris Cité University (USPC) brings together 4 universities, 5 large establishments and 5 internationally renowned research organizations. <> Higher Education and Research establishments Sorbonne Nouvelle University – Paris 3 Paris Descartes University Paris Diderot University University Paris 13 School of Advanced Studies in Public Health (EHESP) FMSH - Maison des sciences de l’homme Foundation National Institute of Oriental Languages and Civilizations (Inalco) Paris Institute of Globe Physics (IPGP) Political science <> Research organizations CNRS Ined Inria Inserm IRD - 1st student community in Île-de-France with 113,000 students including 15% foreign students - 40% of the scientific … Type: | 14 | 7 | 0 | 50 |
 | Laboratoire Quad-Lab [Automatic translation follows] Analysis for safer air The Quad-Lab laboratory is a chemical analysis laboratory, specialized in the following areas of expertise: - Analysis of air quality for industry (atmospheric emissions, occupational exposure), and for the tertiary sector (indoor air) - Analysis of biogas and gas matrices of all types: process gas, bottled gas, etc. Created in 1993, the laboratory has developed solid skills in these four professions: - Analysis of the most varied chemical compounds on many different samples - Provision of sampling equipment: tubes, bags for gas sampling, sparging, etc. - Method development (custom-developed analytical methods) - Advice … | 1 | 0 | 0 | 11 |
 | Agilent Technologies Let’s Bring Great Science to Life. Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s … Type: | 15 | 2 | 0 | 17,329 |
 | Broad Institute of MIT and Harvard The Broad Institute brings together a diverse group of individuals from across its partner institutions — undergraduate and graduate students, postdoctoral fellows, professional scientists, administrative professionals, and academic faculty. The culture and environment at the Broad is designed to encourage creativity and to engage all participants, regardless of role or seniority, in the mission of the Institute. Within this setting, researchers are empowered — both intellectually and technically — to confront even the most difficult biomedical challenges. The Institute’s organization is unique among biomedical research institutions. It encompasses three types of organizational units: core member laboratories, programs and platforms. Scientists … Type: | 4 | 4 | 0 | 3,255 |
 | Government of Alberta Bringing you information about government news and services. Comment rules: http://alberta.ca/SMComments Work with the Alberta government to build a stronger province for current and future generations. We offer diverse and rewarding employment opportunities in an environment that encourages continuous learning and career growth. We are one of the largest employers in Alberta with over 27,000 employees throughout the province. We are an award winning organization that values respect, accountability, integrity, and excellence. Our employees share a common vision of proudly working together to build a stronger province and make a positive and lasting difference in the lives of Albertans. The … Type: | 11 | 3 | 0 | 17,110 |
 | Calliditas Therapeutics Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Type: | 5 | 2 | 0 | 228 |
 | EDF (UK) We’re investing in wind, nuclear and solar to help prevent future energy crises and help Britain achieve Net Zero. EDF is helping Britain achieve Net Zero by leading the transition to a cleaner, low-emission, electric future and helping prevent future energy crises. Our nuclear fleet has supplied low-carbon electricity to UK homes for more than 40 years, and we’re helping with the development of new nuclear stations at Hinkley Point C and Sizewell C. But we’re not stopping there. EDF is also investing in wind, solar and battery storage technology and helping customers decarbonise their homes and businesses through low-carbon … Type: | 33 | 5 | 0 | 8,108 |
 | American College of Clinical Pharmacy (ACCP) Dedicated to Excellence in Clinical Pharmacy Practice, Research, and Education The American College of Clinical Pharmacy (ACCP) is a professional and scientific society that provides leadership, education, advocacy, and resources enabling clinical pharmacists to achieve excellence in practice, research, and education. ACCP's membership is composed of practitioners, scientists, educators, administrators, students, residents, fellows, and others committed to excellence in clinical pharmacy and patient pharmacotherapy. clinical pharmacy, education, networking, and advocacy Type: | 1 | 1 | 0 | 188 |
 | Coventya COVENTYA develops and supplies specialty chemicals for surface finishing in over 60 countries and 5 continents. Our customers include both captive surface treatment and job shop platers that capitalize on our innovative technology, responsive service and numerous OEM product approvals. With a full line of products that find use in many industries from automobiles and oil fields to computers and fashion it is clear that Coventya products touch our lives each and every day. What makes COVENTYA stand out? The very nature of the electroplating industry requires a continuous blend of pure science and practical field experience. Our Research Chemists … Type: | 2 | 0 | 0 | 269 |
 | BD BD is a global medical technology company that is advancing the world of health. www.bd.com BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians’ … Type: | 34 | 10 | 0 | 44,575 |
 | Universitat Autònoma de Barcelona A campus university where you can live unique experiences. The UAB is a young, public and groundbreaking university. A leader in international rankings and a benchmark in research. Barcelonian, Catalan and international. A transformative, supportive, diverse and egalitarian, sustainable and healthy, participative and cultural university. And a campus university where you can live unique experiences. Type: | 9 | 1 | 0 | 7,163 |
 | Gembloux Agro-Bio Tech [Automatic translation follows] At the forefront of technology, sustainable development and eco-innovation A faculty at the forefront of sustainable development and eco-innovation, Gembloux Agro Bio Tech is dedicated exclusively to agronomic sciences and biological engineering which includes life sciences and environmental management. Gembloux Agro-Bio Tech trains bioengineers through a comprehensive five-year program. Four distinct study streams allow students to specialize in key areas of life sciences: environmental sciences and technologies, management of forests and natural spaces, agricultural sciences, chemistry and bioindustries. Gembloux Agro-Bio Tech is also responsible for the first year of the bachelor's degree in landscape architecture, a training … Type: | 3 | 2 | 0 | 219 |
 | American Society of Clinical Oncology (ASCO) Conquering cancer through research, education, and promotion of the highest quality, equitable patient care. Founded in 1964, the American Society of Clinical Oncology (ASCO) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents nearly 50,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality and equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO’s Conquer Cancer Foundation supports the Society by funding groundbreaking research and … Type: | 4 | 4 | 0 | 821 |
 |  Skinjay Paris Une expérience unique d'aromathérapie directement dans l'eau de la douche🚿 Un moment 100% bien-être pour vos clients ✨ For many of us, SHOWER TIME is one of the most essential daily pleasures 🚿 Skinjay has adapted the famous coffee capsule concept to the shower to deliver natural cosmetics, organic essential oils and exclusive fragrances into your shower's water 🛁💧 We are committed to providing the best : 100% Made In France 100 % Natural perfumes 100 % Eco-friendly 100% Easy to install and to use 100 % Well being ! To meet the needs of hospitality professionals to enrich the … Type: | 7 | 3 | 1 | 1 |
 |  Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. Gene Therapy Type: | 2 | 0 | 1 | 31 |
 | Cocktail sante [Automatic translation follows] Interactive cocktail brings together Online image banks, photos, videos, and private image banks Type: | 1 | 0 | 1 | 1 |
 | Executive Service Corps Our mission is to make nonprofits successful. We provide consulting and coaching, helping millions of people annually. Executive Service Corps is the premier nonprofit consultancy that engages highly skilled professionals who use their experience and expertise to provide nonprofits with the consulting services they need to be successful. Each year we achieve our mission by providing exceptional consulting and executive coaching services to hundreds of nonprofit organizations, impacting millions of people. Our vision is, "All nonprofits in our community will have access to the services they need to thrive." Board Development, Strategic Planning, Financial Management, Interim Executive Directors, Coaching, Human … | 3 | 1 | 1 | 102 |
 | MaSTherCell Now a part of Catalent Cell & Gene Therapy With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. … Type: | 1 | 1 | 1 | 26 |
 | Genentech About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or patientinfo@gene.com. Community Guidelines: 1. We want to foster … Type: | 45 | 5 | 1 | 20,345 |
 | Sandoz Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Generics, Biosimilars, and Over the counter medicines Type: | 14 | 3 | 1 | 16,662 |
 | Media Affairs MediaAffairs entwickelt Wissen über Medienmärkte. Damit unterscheidet sich das Unternehmen wesentlich von konventionellen Anbietern aus dem Bereich der Medien(resonanz)analyse, die – auf gänzlich andere Art und Weise – Daten über Unternehmen, Personen, Themen usw. sammeln und als Informationen über das mediale Geschehen an ihre Kunden übermitteln. Auch MediaAffairs analysiert Medien, erarbeitet Statistiken über Präsenz, Themenführerschaft u.v.m. Darüber hinaus aber kennen wir die Medienmärkte, die wir im Auftrag unserer Kunden beschreiben. Daraus ergibt sich eine einzigartige Expertise unserer Mitarbeiter, mit der diese jede Information über das mediale Geschehen anreichern. Dies ist eine der wesentlichen Voraussetzungen, die uns für den professionellen Dialog … Type: | 75 | 42 | 1 | 16,540 |
 | Agios Pharmaceuticals Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases. Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. … Type: | 2 | 1 | 1 | 505 |
 | Laboratorios Normon [Automatic translation follows] We are a Spanish pharmaceutical laboratory that has been manufacturing top quality medicines for more than 80 years. We are a Spanish pharmaceutical laboratory that has been manufacturing top quality medicines for more than 85 years. Betting on technology and innovation, we currently have one of the largest and most modern laboratories in Europe. At Normon we have 5 divisions: - Prescription, pioneers and leaders in the Spanish generic market, with the most extensive vademecum on the market. - Dental, number one in dental anesthetics, we have a wide portfolio of dental products. - Hospitals, at the … Type: | 3 | 0 | 1 | 1,936 |
 | Biopredic International Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields. Biopredic International delivers assays, tissues, cells and reagents including: > High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols) > Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions... > Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34... > And other products … Type: | 3 | 2 | 1 | 28 |
 | Imeka We specialize in brain imaging specifically white matter, neuroinflammation, free-water and more. Imaging What Matters. Imeka is currently the only company to combine diffusion imaging and AI to map white matter integrity and get insights on neuroinflammation, demyelination and axonal loss. Therefore, with our non-invasive technology, we minimize risks for our pharma and biotech clients in the development of treatments for neurodegenerative diseases. Imeka’s main goal is to play an influential role in the search and development of cures for brain disease. Imeka’s diffusion imaging tools are able to measure extracellular water fraction (free-water), which is sensitive neuroinflammation. The technology … Type: | 2 | 0 | 1 | 17 |
 | MYPHARMA EDITIONS MYPHARMA EDITIONS is an information services company based out of 17 ALLEE DU SORBIER DES OISEAUX, OLIVET, France. Type: | 5 | 2 | 1 | 2 |
 | Syncona Limited Building the next generation of healthcare companies Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio of 20- 25 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which we are seeking to deliver strong risk-adjusted returns for shareholders. We take a long-term view, underpinned by a strategic capital base which enables us to maintain significant ownership positions in our companies and provides us with control and flexibility over the management of … Type: | 9 | 3 | 1 | 51 |
 | Marie Curie Alumni Association An active, global community of researchers The Marie Curie Alumni Association (MCAA) is an association of researchers who have benefitted or are benefiting from a Marie Curie Action (recently renamed “Marie Skłodowska-Curie Actions” under the “Excellent Science” pillar of EU’s Horizon 2020 Programme for Research). Researchers on the verge of working on a Marie Curie project are also eligible to join. The main objective of the association is to provide its members with a space where they can share experiences and interests. Membership of the MCAA is open to past and current beneficiaries of the European Commission’s successive Marie Curie … Type: | 10 | 0 | 1 | 98 |
 | DeepLife AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, … Type: | 4 | 2 | 1 | 18 |
 | QIAGEN Making improvements in life possible QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, … Type: | 4 | 3 | 1 | 5,169 |
 | Adisseo Building a better future for animal nutrition Adisseo is one of the world's leading experts in feed additives. The group relies on its 8 research centers and its production sites based in Europe, USA, China & Asia Pacific to design, produce and market nutritional solutions for sustainable animal feed. With more than 2,650 employees, it serves around 4,200 customers in over 110 different countries through its global distribution network. In 2022, Adisseo achieved a turnover of over 2.04 billion Euros. Adisseo is one of the main subsidiaries of China National BlueStar, leader in the Chinese chemical industry with more than … Type: | 15 | 9 | 1 | 1,283 |
 | BIG direkt gesund [Automatic translation follows] BIG directly healthy – the name has been our program since 1996. Our claim then as now: Health insurance couldn't be more direct! BIG direct healthy – this name has been our program since 1996. Our claim then as now: Health insurance couldn't be more direct. This means, for example, little bureaucracy, no technical jargon and being available to our customers around the clock. Our 920 employees now look after more than 520,000 insured people. This makes us one of the 16 largest nationwide health insurance companies in Germany. We continue to grow and are looking for … Type: | 3 | 1 | 1 | 196 |
 | ESMO - European Society for Medical Oncology A reference for oncology education and information Representing more than 35,000 oncology professionals from 170 countries worldwide, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE. Oncology, Education & Training, CME, Cancer, and Medical Oncology Type: | 11 | 10 | 1 | 362 |
 | Agencia Española de Medicamentos y Productos Sanitarios [Automatic translation follows] We guarantee the quality and effectiveness of medicines, health products, cosmetics and personal care The AEMPS's mission is to guarantee society, from the public service perspective, quality, safety, effectiveness and correct information on medications and products healthcare, in the broadest sense, from his research until its use, in the interest of the protection and promotion of the health of people and animals. Its vision is to consolidate itself as the health authority of reference for citizens and health professionals in matters guarantees of quality, safety, effectiveness, information and accessibility of medicines and health products Medicines, Clinical trials, … Type: | 14 | 7 | 1 | 494 |
 | EUPATI European Patients' Academy on Therapeutic Innovation The European Patients’ Academy on Therapeutic Innovation (EUPATI) provides education and training for patients and patient representatives on the process of medicines research and development (R&D). The trained patient experts are key to realising meaningful patient engagement in medicines R&D, regulatory deliberations and other activities. EUPATI was established by the Innovative Medicines Initiative (IMI) in 2012, and was hosted by the European Patients’ Forum (EPF) as a Public-Private Partnership Programme 2017-2020. EUPATI is today established as an independent non-profit Foundation in the Netherlands and has 24 National Platforms in Europe and in Japan. “We … Type: | 10 | 3 | 1 | 48 |
 | CAS The Fabric of Innovation At CAS, our passion is advancing scientific progress. As a leader in scientific information solutions, we curate, connect, and analyze the world’s published science to accelerate breakthroughs. CAS Solutions: Connecting research, patent, regulatory, and business professionals to the data and insights they need, our solutions speed progress through each phase of your pipeline. CAS Expertise: Our team of scientists and technologists embody a wealth of experience across disciplines and collectively speak more than 50 languages fueling our unique capabilities and insights. CAS Data: Our scientists curate, connect, and analyze the valuable data disclosed in scientific publications … Type: | 1 | 0 | 1 | 4,142 |
 | Kymera Therapeutics Inventing a new class of medicines using Targeted Protein Degradation Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged … Type: | 2 | 0 | 1 | 210 |
 | Karyopharm Therapeutics Inc. Discovers, develops and commercializes novel, life-changing cancer therapies in disease areas with high unmet need. Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As leaders in XPO1 inhibition whose mission is to improve lives and defeat cancer, Karyopharm has created a focused pipeline targeting multiple high, unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL). oncology, pharmaceutical, biotech, multiplemyeloma, lymphoma, solidtumors, glioblastoma, clinicalresearch, clinicaltrials, research, drugdiscovery, medical, and healthcare Type: | 4 | 0 | 1 | 410 |
 | Pileje [Automatic translation follows] For 30 years, PiLeJe has distributed health solutions aimed at sustainably improving the quality and healthy life expectancy of patients with functional disorders, risk factors or chronic diseases. Complementary to medications, the health solutions developed by PiLeJe are prescribed by health professionals on the basis of individualized advice. To sustainably improve patient health, PiLeJe has expertise in four areas: health through microbiota, micronutrition, phytotherapy and medical nutrition. Key Figures: 300 employees spread across 5 sites in France 318 product references available Present in 35 countries including 6 subsidiaries (Spain, Benelux, Italy, Switzerland, Germany and Sweden) Micronutrition, Individualized … Type: | 10 | 2 | 1 | 478 |
 | Eligo Bioscience Precision medicines for the microbiome Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing. | 15 | 8 | 2 | 41 |
 | Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR TTM) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers. oncology, cancer, biotechnology, immunotherapy, CAR T, and autoimmune Type: | 4 | 2 | 2 | 290 |
 | Mayoly [Automatic translation follows] Taking care to heart Through its subsidiaries, Mayoly is a family-owned, independent, French pharmaceutical and dermatological laboratory with an international footprint. For more than a century, it has successfully been growing its business with a focus on Gastroenterology and Dermocosmetics. Our French industrial heritage relates to our values of Responsibility, Pragmatism and Caring. We strive passionately and tirelessly to provide patients and people with the best possible healthcare daily, and aim to establish ourselves as a leader in Consumer Healthcare over the coming decades Our know-how applies to several therapeutic areas, such as gastroenterology, rheumatology, ENT, general … Type: | 8 | 1 | 2 | 878 |
 | SOL France [Automatic translation follows] Learn and Act #Together SoL France cultivates the energy of learning and acting together, at the service of people and organizations committed to the conscious and sustainable development of society. Type: | 4 | 1 | 2 | 9 |
 | Viridian Therapeutics, Inc. Engineering Medicines To Improve Patient Care Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian's most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Waltham, Massachusetts. Type: | 2 | 1 | 2 | 124 |
 | Intensity Therapeutics, Inc. A clinical stage biotechnology company whose mission is to create safer and more efficacious cancer therapies. Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected … Type: | 3 | 1 | 2 | 13 |
 | OneGuild Advancing Innovation for Better Diabetes Care OneGuild, the new name for the Peter Sheehan Diabetes Care Foundation (PSDCF), is a 501(c)3 non-profit organization uniting research organizations, health systems, and industry leaders to spur innovation that prevents diabetes and its complications, educate patients and professionals, and convene scientific leaders to advance research. Type 2 Diabetes, Population Health, Type 2 Diabetes Prevention, Type 2 Diabetes Management, Type 2 Diabetes Complications, Scientific Education, and Public Education Type: | 2 | 1 | 2 | 2 |
 | J. Craig Venter Institute The J. Craig Venter Institute was formed in October 2006 through the merger of several affiliated and legacy organizations — The Institute for Genomic Research (TIGR) and The Center for the Advancement of Genomics (TCAG), The J. Craig Venter Science Foundation, The Joint Technology Center, and the Institute for Biological Energy Alternatives (IBEA). Today all these organizations have become one large multidisciplinary genomic-focused organization. With more than 250 scientists and staff, more than 250,000 square feet of laboratory space, and locations in Rockville, Maryland and La Jolla, California, JCVI is a world leader in genomic research. Please visit our web … Type: | 7 | 4 | 2 | 193 |
 | Council of Academic Hospitals of Ontario (CAHO) CAHO represents Ontario’s 23 research hospitals that play a unique and vital role in the province’s health care system. The Council of Academic Hospitals of Ontario (CAHO) represents Ontario’s 23 research hospitals that play a unique and vital role in the province’s health care system. Collectively, we provide advanced patient care services, train the next generation of health care professionals, and conduct leading-edge research to discover tomorrow’s care today. On the foundation of this work, we generate the expertise and evidence to drive change as system leaders, building a healthier, wealthier, smarter Ontario. Discover how at www.healthierwealthiersmarter.ca, and follow the … Type: | 3 | 0 | 2 | 7 |
 | Nektar Therapeutics Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. Drug Development and Polymer Conjugate Chemistry Type: | 5 | 0 | 2 | 583 |
 | Vibiosphen From Microbes to One Health. Taylor made R&D to tackle infectious diseases. Vibiosphen is a SME healthcare biotechnology in infectious diseases founded in 2014. Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, the One Health concept promotes a global effort to achieve the best health for people, animals, and the environment. In this context, Vibiosphen takes part of the efforts that are underway to develop new anti-infective therapies, to rejuvenate the antibiotic pipeline, develop novel antibiotics, and discover innovative therapeutic strategies for priority pathogens. Based on its pluridisciplinary and integrated approaches, Vibiosphen, with more than … Type: | 4 | 2 | 2 | 8 |
 | Global Heart Hub The Alliance of Heart Patient Organisations The Global Heart Hub is the first global non-profit organisation established to provide a voice for those affected by cardiovascular disease. We are an alliance of heart patient organisations, aiming to create a unified global voice for those living with or affected by heart disease. Type: | 3 | 2 | 2 | 18 |
 | Cholangiocarcinoma Foundation Our mission is to find a cure and improve the quality of life for those affected by cholangiocarcinoma (bileduct cancer) The Cholangiocarcinoma Foundation is a 501(c)(3) non-profit organization. Its vision is to bring about a CURE for cholangiocarcinoma, more commonly known as bile-duct cancer, through Collaboration, Understanding, Research and Education. This Foundation was born out of love, and every hour that has gone into it has been volunteered by board members each one having lost a loved one to cholangiocarcinoma or suffering from cholangiocarcinoma and surviving. Many others have volunteered their time and energy to filling a need. Our vision … Type: | 4 | 2 | 2 | 45 |
 | Chemetall A global leader of surface treatment technologies The Surface Treatment global business unit of BASF's Coatings division, operating under the Chemetall brand, is a leading supplier of applied surface treatment technologies for metal, plastic, and glass substrates. These specialty chemicals are used in a wide range of industries and end-markets, such as, but not limited to, automotive, aerospace, aluminum finishing, coil, and metal forming, supported by a large network of technical specialists. The portfolio includes solutions for ensuring corrosion protection and coating adhesion, forming and machining of substrates, applications to prepare surfaces for painting processes, and sealants for specific applications … Type: | 4 | 1 | 2 | 1,489 |
 | Kite Pharma At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer. At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit. Since 2009, Kite has been at the forefront of cancer immunotherapy. Today, we are proud to be the leader in engineered T cell therapy for hematologic malignancies, but we recognize that this is just the beginning. Patients are at the heart of our focus on the … Type: | 10 | 3 | 2 | 4,097 |
 | OSE Immunotherapeutics Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients OSE Immunotherapeutics is an integrated biotech company focused on developing first-in-class assets targeting cancer and inflammatory diseases. A current well-balanced first-in-class clinical pipeline including: • Tedopi® (T-cell specific immunotherapy): Company’s most advanced product; positive results for Ph 3 in NSCLC in secondary resistance after CKI failure. Other sponsored combo Ph 2 trials in solid tumors ongoing. • OSE-279 (anti-PD1) advanced preclinical stage • OSE-127 (humanized mAb antagonist of IL-7R); ongoing Ph 2 in Ulcerative Colitis; ongoing preclinical research in leukemia • VEL-101/FR104 (anti-CD28 mAb) developed in partnership with Veloxis in transplantation; ongoing … Type: | 9 | 6 | 2 | 1 |
 | Université Paris Lumières [Automatic translation follows] A ComUE at the heart of the human and social sciences ComUE Université Paris Lumières (UPL) was founded in 2014 by the University of Paris 8, the University of Paris Nanterre and the CNRS. ENS Louis-Lumière, INSHEA and around ten world-class museums, cultural and scientific institutions in the Ile-de-France region are associated with it. They contribute to the specificity of the UPL in the Ile-de-France region. The International College of Philosophy (CIPh) became a component of the ComUE in January 2017. Our ComUE has also included since 2016 a “New College of Political Studies” (NCEP) which offers … Type: | 5 | 0 | 2 | 29 |
 | Paidy [Automatic translation follows] Japan's pioneer and leading BNPL platform with the mission to spread trust through society and give people room to dream Paidy Co., Ltd. provides Paidy, an industry-leading Buy Now Pay Later service in Japan. You can buy what you want right away using just your smartphone, and pay in bulk later. The app has been used by many people due to its simple UX, the convenience of being able to make payments in 3, 6, or 12 installments with no charge for the next month or in installments*, and the ability to manage money wisely on a … Type: | 15 | 0 | 2 | 191 |
 | BGene Genetics Believe in Nature, belong to Future BGene aims at developing sustainable and resilient production ways for high value added, biobased molecules. To this end, BGene develops expertise in domains such as molecular biology, microbiology, biochemistry, process engineering and computer sciences. Food and feed, pharma, cosmetics, chemistry, and environment are among the diverse markets that BGene can address thanks to the cutting-edge bioprocesses developed by BGene know-how. Strain engineering, Microorganism chromosome engineering, Synthetic Biology, Molecular Biology, Bioinformatics, and Bioprocess Type: | 7 | 6 | 2 | 24 |
 | Eurosafe CRO [Automatic translation follows] Eurosafe is a Good Laboratory Practices (GLP) certified contract research company (CRO), specializing in human and veterinary pharmaceuticals, cosmetic products (ingredients and finished products), food supplements and medical devices. Depending on your products, a single contact, surrounded by scientists and regulatory experts, supports you to define and carry out regulatory procedures, carry out ADME (Absorption, Distribution, Metabolism and Elimination), safety, tolerance or efficiency needed to put your products on the market. Eurosafe is a unique CRO with multiple skills, organized around 3 complementary areas: - In vitro tests - Tests on volunteers - Toxicological and regulatory expertise … Type: | 2 | 0 | 2 | 18 |
 | Embleema Embleema is the regulatory-grade health data platform to accelerate new drug discovery and release new treatments sooner Embleema's software platform brings precision medicine sooner to patients by collecting and generating regulatory-grade evidence. Our platform natively unifies clinical, molecular and real-world data and is the sole one used by the FDA for its regulatory evaluation of health products involving genomic datasets. The protocols and algorithms contained in our platform are also the basis for future CDISC standards for cell and gene therapies. The FDA also uses our platform to produce regulatory grade genomic sequences for SARS-CoV-2 and other microbial pathogens (project … Type: | 7 | 3 | 3 | 19 |
 | Commonwealth of Massachusetts Welcome to Massachusetts Year after year, the Commonwealth of Massachusetts has continued to pioneer bold legislative actions and programs, some of which have been embraced on a national scale. We are always looking for talented individuals to help us maintain this momentum and improve the services that millions of people depend on every day. If you’re looking for an innovative work environment where you can really make a difference, check out the job opportunities with the Commonwealth of Massachusetts. This page is managed according to the Mass.gov social media policy: https://www.mass.gov/info-details/massgov-social-media-policy. Type: | 8 | 2 | 3 | 13,708 |
 | BIO-MODELING SYSTEMS The Mechanisms-Based Medicine Company Bio-Modeling Systems is the world’s first Mechanisms-Based medicine company that changed the discovery paradigm to create novel medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADITM Discovery models. We propose to R&D & Translational Medicine Executives, robust alternative decision-making to de-risk, save time, costs, and novel cost-effective diagnostics/therapies for their businesses. Created in 2004, profitable since 2006, thanks to our recurrent clients, we confirmed with our partners CADITM Discovery capability to generate outstanding value through: • Strong & long term strategic R&D collaborations (>100 … Type: | 5 | 0 | 3 | 5 |
 | Excelya Expertly delivering clinical trials operations, with care. Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence. Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, … Type: | 8 | 2 | 3 | 702 |
 | Beckman Coulter Life Sciences (formerly Labcyte Inc.) Echo liquid handlers and Access workstations are now Beckman Coulter Life Sciences products. Labcyte is now Beckman Coulter Life Sciences! Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality … Type: | 4 | 1 | 3 | 54 |
 | Forward Forward was founded in 2004. Since then we've expanded from our roots in search to establish several successful web businesses with activity in many different countries and languages. But we're called Forward for a reason - we're not interested in looking back, we want to advance, to continue to grow and to make a difference. Our Companies • uSwitch - the UK’s leading energy switching site • Forward3D - the fastest growing digital agency in the UK • InvisibleHand - real-time price comparison tool • Omio - the ultimate mobile phone comparison site • JustShops – a range of specialty … | 2 | 0 | 3 | 43 |
 | MiNA Therapeutics Activating RNA, mastering disease Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases. Gene activation, RNA therapeutics, Liver disease, and Drug discovery Type: | 3 | 0 | 3 | 37 |
 | American Brain Tumor Association Providing and pursuing answers. Founded in 1973, the American Brain Tumor Association was the first and only national patient advocacy organization committed to funding brain tumor research and providing support and education programs for people of all tumor types and all ages. The mission of the American Brain Tumor Association is to advance the understanding and treatment of brain tumors with the goals of improving, extending and, ultimately, saving the lives of those impacted by a brain tumor diagnosis. We do this through interactions and engagements with brain tumor patients and their families, collaborations with allied groups and organizations, and … Type: | 6 | 1 | 3 | 56 |
 | Fiera Milano SpA Fiera Milano organizza, ospita e gestisce eventi di livello internazionale nei suoi padiglioni e nel mondo, dal 1920. Fiera Milano is the leading exhibition Group in Italy and one of the top in the world. Expertise, excellence in professional exhibitions and services and cutting edge facilities, as well as its success in the foremost international conference management, all make Fiera Milano the ideal partner for promotion, development and internationalisation of any company. Fiera Milano helps companies expand their business opportunities in Italy and abroad; communicate most effectively with reference markets; nurture human capital through continual professional training; share knowledge at … Type: | 12 | 3 | 3 | 615 |
 | Vaiomer Pioneer in Blood and Tissue Microbiomes. Worldwide Expert in Microbiome Profiling from low bacterial biomass samples Pioneer and expert in blood and tissue microbiota, Vaiomer carries out microbiota studies, in the fields of human and animal health, for preclinical and clinical research, CROs, dermocosmetics, nutraceuticals and pharmaceutical / biotech companies. We perform microbiota studies from a very wide variety of biological samples (blood, adipose tissue, biopsies, tumors, and more classically skin, saliva, faeces, etc.): DNA extraction, quantification by qPCR, sequencing metagenomics, Bioinformatics, Biostatistics. Upstream and downstream of the studies: support for the experimental design and the drafting of study protocols, … Type: | 5 | 1 | 3 | 10 |
 | MYSPHERA Save Time. Improve Care At MYSPHERA we put our expertise at the service of technology and people to automate, simplify and speed up🚀 the most complex processes of a healthcare organization. Our goal🎯 is to free up health professionals from spending their time on anything but patient care. RTLS and RFID technologies., Real Time Location Systems., IoT healthcare, and IoT technologies Type: | 12 | 1 | 3 | 49 |
 | R++, L'Essentiel [Automatic translation follows] Statistical analysis software designed by and for doctors R++, L'Essentiel is statistical analysis software for clinical research. R++ is ergonomic software tailor-made by and for doctors. Particularly easy to use, its objective is to allow doctors and interns to carry out their statistical analyzes very quickly, then to publish at a high level in complete autonomy. R++, The Essential: faster, bigger... simpler! Computer science, Statistics, Software, R&D, R, Rstats, data analysis, R software, Statistical software, Statistical analysis, R language, R training, data management, data scientist, data mining, analysis software, data management, tool statistics, clinical research, and research Type: | 3 | 0 | 3 | 8 |
 | Team MNM Consulting [Automatic translation follows] The @mnmtouch, baptized by our customers: it is this little + which is our signature.MNM Consulting Consulting and Innovation Cabinet #Openmnm Type: | 4 | 1 | 3 | 52 |
 | Evotec #researchneverstops Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and … Type: | 5 | 2 | 3 | 4,958 |
 | Zymeworks Inc. Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases. Zymeworks (NASDAQ:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead clinical candidate, zanidatamab, is a novel AzymetricTM HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. Zymeworks’ second product candidate, Zanidatamab Zovodotin (ZW49), is a bispecific antibody-drug conjugate currently in … Type: | 10 | 0 | 3 | 279 |
 | BioCurate Pty Ltd A Bold New Venture: We are an Australian Venture Catalyst for New Drug Discovery In order to realise the full potential of Australia’s innovation opportunities, new approaches are required to take discoveries through the process of translation and early commercialisation - the so-called ‘valley of death’. It is precisely this ‘valley’ that a newly launched $80 million enterprise, BioCurate Pty Ltd, aims to traverse in the field of biomedical drug development. BioCurate has been formed as a joint venture between two leading Australian Universities, the University of Melbourne and Monash University. As an independent venture catalyst, BioCurate will target this … Type: | 4 | 2 | 3 | 15 |
 | Mintz Built on excellence. Driven by change. Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C. is a general practice, full-service Am Law 100 law firm employing approximately 600+ attorneys serving clients worldwide. We are headquartered at One Financial Center in Boston’s Financial District and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, Washington, DC, and an office in Toronto, Canada. Mintz was founded in 1933 by Haskell Cohn and Benjamin Levin. The firm’s Managing Member is Robert I. Bodian. Our collaborative attorneys work within four core practice areas — Transactional, Intellectual Property, Litigation & … Type: | 8 | 2 | 3 | 1,328 |
 | PDC*line Pharma A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) Founded in 2014 as a spin-off of the French Blood Bank (EFS), PDC*line Pharma is a French-Belgian biotech company that develops an innovative class of active immunotherapies to treat cancers. This cancer vaccine contains proprietary, potent, and scalable plasmacytoid dendritic cell line (PDC*line), whose remarkable characteristics make them excellently suited for immunotherapy. PDC*line is much more potent to prime and boost antitumor antigen, including neoantigens, specific cytotoxic T-cells than conventional vaccines and improves the response to checkpoint inhibitors. PDC*line offers unique advantages: - PDC*line … Type: | 9 | 1 | 4 | 37 |
 | CureMatch, Inc. AI-based Precision Medicine Decision Support for Oncology CureMatch is a leader in AI-based precision medicine, digital decision support solutions that support cancer treatment. Created to empower oncologists with world-class research and sophisticated AI algorithms, the CureMatch Decision Support System assists the doctor with understanding therapeutic options that are personalized to the unique molecular profile of the individual patient’s tumor. digital health, oncology, decision support software, AI, precision medicine, and combination therapy Type: | 5 | 1 | 4 | 25 |
 | Cytokinetics Empowering Muscle Empowering Lives Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in … Type: | 6 | 1 | 4 | 475 |
 | Third Rock Ventures We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives. THE THIRD ROCK TEAM Our team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy and plan needed to … Type: | 7 | 2 | 4 | 138 |
 | BIOGARAN [Automatic translation follows] The box that takes care of you. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new, still little-known market: generic medicines. Offering patients quality medicines with recognized effectiveness whose patent has fallen into the public domain then required a new type of know-how that traditional laboratories did not possess. Our know-how is available through different ranges: from minor everyday ailments with the Biogaran Conseil® range, to more serious pathologies with prescription medications. Whatever the pathology, patient health is at the heart of Biogaran's concerns and the same rigor … Type: | 8 | 2 | 4 | 506 |
 | Oncopole [Automatic translation follows] Research, development and investment center to accelerate cancer research in Quebec Research, development and investment center to accelerate the fight against cancer. Type: | 6 | 2 | 4 | 18 |
 | DISTINGO Bank [Automatic translation follows] Savings solutions by DISTINGO Bank. #GrowYourSavings #LabelExcellence2024 Launched in 2013, DISTINGO Bank is the deposit activity resulting from the joint venture between Santander Consumer Finance and Stellantis Financial Services. It offers 100% online savings solutions, with some of the highest rates of return on the market: the Savings Book and Term Accounts (CAT). DISTINGO Bank uses all its know-how and experience in the development of savings products used in automobile financing, insurance and services in order to meet all the needs of customer networks of brands such as Peugeot , Citroën, DS or FIAT from the Stellantis … Type: | 6 | 0 | 4 | 44 |
 | OMass Therapeutics OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Science Enterprises. Type: | 12 | 3 | 4 | 77 |
 | Ondalys [Automatic translation follows] Experts in Chemometrics, Machine Learning & Data Analytics. Contact us for any need in services, training or software. Chemometrics or how to make your data speak! Ondalys is a service company that specializes in support and training in data analysis, chemometrics and multivariate statistics. Ondalys supports its clients in the interpretation of instrumental and sensory data in order to extract all the relevant and usable information for decision-making. We operate in different sectors: • Agronomy • Agri-food • Pharmaceutical industries • Chemistry • Environment • ... Multivariate modeling, Spectroscopic calibrations, Data mining, Exploratory analysis, Process control, Quality … Type: | 6 | 0 | 5 | 9 |
 | Laval économique [Automatic translation follows] Economic Laval ensures the promotion of economic development through the search for new investments, the reception of businesses and the support of those established in its territory while seeking to accelerate the realization of investment projects and innovative initiatives in the territory . More details at www.lavaleconomique.com. Economic development, Business promotion, Assistance for business establishment, and Assistance for internationalization Type: | 17 | 3 | 5 | 44 |
 | Oncodesign Services A leading CRO in drug discovery and preclinical services Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the discovery of innovative therapies with unmet medical needs, in particular in oncology, inflammation and infectious diseases. From target identification, hit-to-lead and lead optimization to IND filing, Oncodesign Services support the R&D programs of customers globally (whether pharmaceutical companies, biotechs, public research institutions, etc.). Oncodesign Services offers a full spectrum of services in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, in vivo/In vitro pharmacology (including humanized models). This … Type: | 12 | 8 | 5 | 20 |
 | SFC - Société Française de Cardiologie [Automatic translation follows] Strength for the heart Created in 1937 by Charles Laubry, the French Society of Cardiology today has nearly 7,042 members. Its Board of Directors (28 people whose mandate is 4 years) elects its Bureau and its President. Article 1 of the association's statutes defines its three objectives: - develop and propagate scientific research in the cardiovascular field; - ensure quality continuing training; - indicate the rules for the proper exercise of cardiological practice, in particular by publishing recommendations. On the scientific level, the driving force of the French Society of Cardiology is represented by its 4 subsidiaries … Type: | 14 | 9 | 5 | 49 |
 | Groupe LesJeudis [Automatic translation follows] Make IT happen! CareerBuilder offers recruitment and employer branding services. In France we publish the sites: - CareerBuilder.fr, - LesJeudis.com (No. 1 for IT jobs), - Erecrut.com (commerce/sales), - Phonemploi.com (customer relations), - RecruLex.com (legal jobs), - CAO-emplois.com (CAD professions) - Engineer-jobs.com. - Toplanguagejobs.fr Each month, there are 1.2 million unique visitors who browse the 16,000 job offers made available to them. Careerbuilder.com is the largest online recruiting site in the United States, with more than 26 million unique visitors, 1 million job postings and 31 million resumes online. CareerBuilder partners with the world's largest employers, providing … Type: | 6 | 1 | 5 | 13 |
 | GASSER GASSER is a real estate company based out of Kolbotn, ÅL, Ål, Norway. | 5 | 0 | 5 | 3 |
 | Premios Aspid España [Automatic translation follows] Creatives for health. Creatives for health. Ibero-American health and pharmacy communication and advertising awards. Organizer and official media PMFARMA Magazine -> Rules for the poster contest: http://www.premiosapid.net/es/cartel/bases/ Advertising, healthcare, awards, and creativity Type: | 8 | 2 | 5 | N/A |
 | WeHealthTM by Servier WeHealthTM by Servier wants to improve the patients and HCPs daily live by using digital technologies. WeHealthTM Digital Medicine is the Servier Group’s exciting new eHealth department. Its goal is to deliver an effective response to emerging healthcare market demand for eHealth or connected health, with an approach centered on the patient. WeHealthTM is driven by the spirit of entrepreneurship and intends to invest in innovations created in partnership with startups worldwide. Type: | 10 | 6 | 5 | 8 |
 | Harvard Management Company Harvard Management Company, Inc. or HMC is an American investment management corporation, a wholly owned subsidiary of Harvard University charged with managing the university's endowment, pension assets, working capital, and non-cash gifts. HMC is best known for managing the university's $53.2 billion endowment, the largest endowment in higher education in the United States. Type: | 115 | 61 | 5 | 154 |
 | ASK Avocats Associés [Automatic translation follows] Criminal Law | Medical Law | Social law | Family law before all courts Law firm located in RENNES, practicing mainly in the field of criminal law, social law, family law and medical and hospital liability law. Criminal law, Social law, and Medical law | 5 | 0 | 5 | 3 |
Startup